
Keywords: فعالکننده پروتئازوم; AGEs; advanced glycation endproducts; ApoJ/CLU; Apolipoprotein J/Clusterin; ROS; reactive oxygen species; PBMC; peripheral blood mononuclear cells; Msr; methionine sulfoxide reductase; GalNAc; N-acetylgalactosamine; GlcNAc; N-acetylglucosamine; ER; endopl